; and (B) a description of Federal requirements, including requirements under the Medicare program, for hospice programs regarding the disposal of controlled substances in a home setting, and oversight of compliance with those requirements. (b) Report Not later than 18 months after the date of enactment of this Act, the Comptroller General shall submit to Congress a report containing the results of the study conducted under subsection (a), together with recommendations, if any, for such legislation and administrative action as the Comptroller General determines appropriate. 308. Delivery of a controlled substance by a pharmacy to be administered by injection, implantation, or intrathecal pump (a) In general The Controlled Substances Act is amended by inserting after section 309 ( 21 U.S.C. 829 ) the following: 309A. Delivery of a controlled substance by a pharmacy to an administering practitioner (a) In general Notwithstanding section 102(10), a pharmacy may deliver a controlled substance to a practitioner in accordance with a prescription that meets the requirements of this title and the regulations issued by the Attorney General under this title, for the purpose of administering of the controlled substance by the practitioner if— (1) the controlled substance is delivered by the pharmacy to the prescribing practitioner or the practitioner administering the controlled substance, as applicable, at the location listed on the practitioner’s certificate of registration issued under this title; (2) (A) in the case of administering of the controlled substance for the purpose of maintenance or detoxification treatment under section 303(g)(2)— (i) the practitioner who issued the prescription is a qualifying practitioner authorized under, and acting within the scope of that section; and (ii) the controlled substance is to be administered by injection or implantation